Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Fran??ois Meyer
Affiliation
Laval University
ORCID
Career Start Year
1986
Papers
89
H Index
39
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
30651130
A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
J Otolaryngol Head Neck Surg
2019
28766373
Prediction of the outcome of children who had a language delay at age 2 when they are aged 4: Still a challenge.
Int J Speech Lang Pathol
2018
29951282
Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients.
Cancers Head Neck
2018
26702991
Randomized non-inferiority trial of Bicalutamide and Dutasteride versus LHRH agonists for prostate volume reduction prior to I-125 permanent implant brachytherapy for prostate cancer.
Radiother Oncol
2016
27173062
A genome-wide association study of non-HPV-related head and neck squamous cell carcinoma identifies prognostic genetic sequence variants in the MAP-kinase and hormone pathways.
Cancer Epidemiol
2016
23169318
Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients.
Int J Cancer
2013
21424341
Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Support Care Cancer
2012
22076708
Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival.
Clin Cancer Res
2012
22009713
Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers.
Cancer
2012
21640495
Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy.
Int J Radiat Oncol Biol Phys
2012
20533282
Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients.
Int J Cancer
2011
20103685
Serum prognostic markers in head and neck cancer.
Clin Cancer Res
2010
20825973
Matrix metalloproteinase 9 is associated with Gleason score in prostate cancer but not with prognosis.
Hum Pathol
2010
20530383
Three profiles of language abilities in toddlers with an expressive vocabulary delay: variations on a theme.
J Speech Lang Hear Res
2010
20187097
Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer.
Cancer
2010
19451440
Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy.
J Clin Oncol
2009
17885825
Systematic review of the literature on characteristics of late-talking toddlers.
Int J Lang Commun Disord
2008
18838726
Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies.
Ann Intern Med
2008
18543328
Maintenance bacillus Calmette-Guérin in high-risk nonmuscle-invasive bladder cancer: how much is enough?
Cancer
2008
18329693
Membrane-type-1 matrix metalloproteinase, matrix metalloproteinase 2, and tissue inhibitor of matrix proteinase 2 in prostate cancer: identification of patients with poor prognosis by immunohistochemistry.
Hum Pathol
2008
18349267
Genetic polymorphisms and head and neck cancer outcomes: a review.
Cancer Epidemiol Biomarkers Prev
2008
18059031
Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients.
Int J Cancer
2008
18172254
Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer.
Clin Cancer Res
2008
17927499
Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients.
Nutr Cancer
2007
16643266
Women's perceptions of events impeding or facilitating the detection, investigation and treatment of breast cancer.
Eur J Cancer Care (Engl)
2006
17078346
Implementing the role of patient-navigator nurse at a university hospital centre.
Can Oncol Nurs J
2006
17076947
Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer.
Can J Urol
2006
17116715
Moderate alcohol consumption is more cardioprotective in men with the metabolic syndrome.
J Nutr
2006
16841333
Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients.
Int J Cancer
2006
15800922
Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial.
Int J Cancer
2005
16172243
A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial.
Cancer Epidemiol Biomarkers Prev
2005
15826765
Insulin-like growth factor binding protein 2: an androgen-dependent predictor of prostate cancer survival.
Eur Urol
2005
15812073
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients.
J Natl Cancer Inst
2005
16027437
Randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
J Clin Oncol
2005
15280632
Antihypertensive drug use and the risk of prostate cancer (Canada).
Cancer Causes Control
2004
12772004
Validation of the GSFQ, a self-administered symptom frequency questionnaire for patients with gastroesophageal reflux disease.
Can J Gastroenterol
2003
14679018
Significance of MMP-2 expression in prostate cancer: an immunohistochemical study.
Cancer Res
2003
12845682
Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer.
Int J Cancer
2003
11898936
PSA screening and prostate cancer mortality.
CMAJ
2002
11502434
Overview consensus statement.
Urology
2001
11307144
Expression of p21 predicts PSA failure in locally advanced prostate cancer treated by prostatectomy.
Int J Cancer
2001
11502453
Duration of neoadjuvant androgen deprivation therapy before radical prostatectomy and disease-free survival in men with prostate cancer.
Urology
2001
10607740
P53 point mutations in initial superficial bladder cancer occur only in tumors from current or recent cigarette smokers.
Carcinogenesis
2000
11175346
Chromosome 9 deletions and recurrence of superficial bladder cancer: identification of four regions of prognostic interest.
Oncogene
2000
11065013
Lifetime occupational physical activity and incidental prostate cancer (Canada).
Cancer Causes Control
2000
10719738
Tumorigenic pathways in low-stage bladder cancer based on p53, MDM2 and p21 phenotypes.
Int J Cancer
2000
10480692
Psychological stress and incidence of ischaemic heart disease.
Int J Epidemiol
1999
10393843
Deletions of the INK4A gene in superficial bladder tumors. Association with recurrence.
Am J Pathol
1999
10325493
Dietary fat and prostate cancer progression and survival.
Eur Urol
1999
10081867
Downward trend in prostate cancer mortality in Quebec and Canada.
J Urol
1999
1 - 50 of 89
Column Actions
Search
Recommended Authors
Mieke Van Hemelrijck
School of Cancer and Pharmaceutical Sciences, King's College London
Career Start Year
2007
Number of shared co-authors
0
Jeanine M Genkinger
Mailman School of Public Health, Columbia University
Career Start Year
2001
Number of shared co-authors
2
David Elashoff
David Geffen School of Medicine at University of California los angeles
Career Start Year
1997
Number of shared co-authors
1
Alexandra L Hanlon
Virginia Tech
Career Start Year
1994
Number of shared co-authors
0
Carmen Rodriguez
Institut de Recherche en Cancerologie de Montpellier
Career Start Year
1993
Number of shared co-authors
2
John R McLaughlin
University of Toronto Dalla Lana School of Public Health
Career Start Year
1988
Number of shared co-authors
3
Hoda Anton-Culver
University of California irvine
Career Start Year
1988
Number of shared co-authors
4
Stephen K Van Den Eeden
Kaiser Permanente Northern California, University of California san francisco
Career Start Year
1985
Number of shared co-authors
4
Jo L Freudenheim
School of Public Health and Health Professions, University at Buffalo
Career Start Year
1985
Number of shared co-authors
3
Jenny Chang-Claude
German Cancer Research Center (DKFZ)
Career Start Year
1984
Number of shared co-authors
5
David Tritchler
University at Buffalo
Career Start Year
1984
Number of shared co-authors
0
Bruce J Trock
Johns Hopkins University School of Medicine
Career Start Year
1984
Number of shared co-authors
3
John A Baron
University of North Carolina at Chapel Hill
Career Start Year
1983
Number of shared co-authors
2
Meir J Stampfer
Brigham and Women's Hospital
Career Start Year
1982
Number of shared co-authors
4
Anna H Wu
University of Southern California
Career Start Year
1981
Number of shared co-authors
3
Thomas E Rohan
Albert Einstein College of Medicine
Career Start Year
1980
Number of shared co-authors
4
Eric J Bergstralh
Mayo Clinic
Career Start Year
1980
Number of shared co-authors
2
Janet L Stanford
Fred Hutchinson Cancer Research Center
Career Start Year
1980
Number of shared co-authors
4
Graham A Colditz
Washington University School of Medicine
Career Start Year
1978
Number of shared co-authors
4
Steven K Clinton
Comprehensive Cancer Center, The Ohio State University
Career Start Year
1978
Number of shared co-authors
1
Scott M Lippman
Moores Cancer Center, university of california san diego
Career Start Year
1977
Number of shared co-authors
0
Kenneth C Chu
Ontario Institute for Cancer Research
Career Start Year
1974
Number of shared co-authors
6
Bernard Rosner
Brigham and Women's Hospital and Harvard Medical School
Career Start Year
1973
Number of shared co-authors
3
Louise A Brinton
National Cancer Institute
Career Start Year
1973
Number of shared co-authors
3
William J Blot
Vanderbilt University Medical Center
Career Start Year
1972
Number of shared co-authors
3
Robert N Hoover
National Cancer Institute
Career Start Year
1971
Number of shared co-authors
4
Robert A Hiatt
University of California San Francisco
Career Start Year
1968
Number of shared co-authors
1
Brian E Henderson
University of Southern California
Career Start Year
1967
Number of shared co-authors
5
Loren Lipworth
Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine
Career Start Year
1964
Number of shared co-authors
2
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Career Start Year
1963
Number of shared co-authors
3
row(s) 1 - 30 of 30
Collaborators
Isabelle Bairati
Laval University Cancer Research Center
Co-authored papers
47
Yves Fradet
CHU de Quebec-Universite Laval
Co-authored papers
24
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Co-authored papers
22
Andr?? Fortin
Laval University, CHU de Quebec
Co-authored papers
11
Louis Lacombe
CHU de Quebec-Universite Laval
Co-authored papers
10
Geoffrey Liu
The Princess Margaret Cancer Centre/University of Toronto
Co-authored papers
8
Wei Xu
Princess Margaret Cancer Centre
Co-authored papers
6
Eric Vigneault
Centre Hospitalier Universitaire de Quebec
Co-authored papers
4
John Waldron
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Co-authored papers
4
David P Goldstein
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers
4
Dangxiao Cheng
University Health Network
Co-authored papers
4
Abul Kalam Azad
University of Dhaka
Co-authored papers
4
Dominique Trudel
Institut du cancer de Montreal
Co-authored papers
3
Xin Qiu
SLR Consulting (Canada) Ltd
Co-authored papers
3
Pilar Galan
Co-authored papers
3
Maryam Mirshams
Princess Margaret Cancer Centre
Co-authored papers
3
Sevtap Savas
Memorial University
Co-authored papers
2
Serge Hercberg
Co-authored papers
2
Lu Cheng
Princess Margaret Cancer Centre and University Health Network, University of Toronto
Co-authored papers
2
Elio Riboli
Co-authored papers
1
Paul Wheatley-Price
The Ottawa Hospital Research Institute
Co-authored papers
1
Brian O'Sullivan
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Co-authored papers
1
Hala Girgis
Toronto General Hospital
Co-authored papers
1
Daryl Waggott
Ontario Institute for Cancer Research
Co-authored papers
1
Göran Hallmans
Co-authored papers
1
James Ho
Co-authored papers
1
Graham G Giles
Co-authored papers
1
Paul C Boutros
University of California los angeles
Co-authored papers
1
Claude Bouchard
Co-authored papers
1
Timothy J Key
Co-authored papers
1
1 - 30